Cardiogenic Shock, ST Elevation Myocardial Infarction
Conditions
Keywords
STEMI, Cardiogenic Shock, Morbidity, Mortality
Brief summary
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.
Detailed description
Cardiovascular disease (CVD) accounts for 40% of mortality in the UAE, which is higher than the global average. Long-term trends, incidence studies, and best practice guidance on Cardiogenic Shock (CS) with ST-elevation Myocardial infarction (STEMI) in the United Arab Emirates (UAE) and the Gulf Cooperation Council (GCC) are limited. Through this retrospective study, investigators aim to identify treatment modalities and trends, hospitalization events, and patient demographics and comorbidities which lead to participant recovery or mortality in Sheikh Khalifa Medical City (SKMC) and Sheikh Shakhbout Medical City (SSMC) tertiary hospitals for patients admitted with STEMI and CS or developed CS after hospitalization with STEMI during January 2020-January 2024.\[200-400 participants\]. Data will be collected from eligible patients' electronic medical records (EMR).
Interventions
None listed
Sponsors
Sheikh Shakhbout Medical City
Sheikh Khalifa Medical City
Abu Dhabi Health Services Company
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age more than 18. * STEMI complicated by cardiogenic shock. * Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock. * Patient admitted between January 2019 to March 2024.
Exclusion criteria
* Age less than 18. * Shock patient not related to Myocardial infarction. * NSTEMI-related cardiogenic shock. * Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock. * Patient not admitted between January 2019 to March 2024.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Analyze STEMI patient with CS disease profile | 5 years | Comorbidities, demographical information, past medical history, morbidity |
| Incidence of CS-complicated AMI events | 5 years | The incidence of CS-complicated AMI events will show an increase over the years because of advanced diagnostic modalities and a clearer definition of CS. |
| Analyze treatment outcomes in the targeted population as per the patient profile | 5 years | Incidence of Mortality |
| Analyze treatment outcomes | 5 years | % of patients who were discharged |
Countries
United Arab Emirates
Contacts
Primary ContactAlina Naeem, MBBS
Backup ContactBabiker Babiker Mohamed Babiker Elsiraj MB Elsiraj, MD
Outcome results
None listed